Opioid Addiction Rehab Centers

Opioid rehab treatment uses medication-assisted treatment (MAT), medical detox, and behavioral therapy to help people recover from addiction to heroin, fentanyl, and prescription painkillers. According to SAMHSA, MAT reduces opioid overdose deaths by approximately 50% and increases treatment retention rates. Below, find evidence-based treatment options and what to expect at each stage of opioid rehab.

Opioid Addiction: Scope and Substances

The CDC reports that opioids were involved in over 81,000 overdose deaths in 2023, with synthetic opioids (primarily illicitly manufactured fentanyl) driving nearly 75% of all opioid-related fatalities. Opioid use disorder (OUD) is a chronic brain condition classified in the DSM-5 that responds to structured medical treatment.

Substances treated in opioid rehab programs:

• Prescription opioids: oxycodone (OxyContin), hydrocodone (Vicodin), morphine, codeine — responsible for roughly 14,700 overdose deaths annually
• Heroin: semi-synthetic opioid often used after prescription opioid dependency develops
• Synthetic opioids: fentanyl (50-100x more potent than morphine), carfentanil, nitazenes
• Polysubstance use: opioids combined with benzodiazepines, alcohol, or stimulants — increases overdose risk 10-fold

Stage 1: Medical Detoxification (3-10 Days)

Medical detox is the first phase of opioid rehab treatment. Opioid withdrawal symptoms — including muscle aches, nausea, insomnia, and intense cravings — typically begin 8-24 hours after last use and peak at 36-72 hours. Medically supervised detox uses tapering protocols with buprenorphine or clonidine to reduce symptom severity by 60-80%, with 24/7 nursing and physician oversight. Detox alone is not treatment — it stabilizes patients for ongoing rehab.

Stage 2: Medication-Assisted Treatment (MAT)

Medication-Assisted Treatment is the clinical gold standard for opioid use disorder. A 2024 NIDA research report confirms that MAT reduces illicit opioid use by 50-75% compared to non-medication approaches. MAT is typically maintained for 12-24 months minimum, with many patients benefiting from longer durations.

Three FDA-approved medications for opioid use disorder:

• Buprenorphine (Suboxone, Sublocade): Partial opioid agonist that reduces cravings and withdrawal; can be prescribed in office-based settings since the 2023 removal of the X-waiver requirement; available as daily sublingual film or monthly injection
• Methadone: Full opioid agonist administered through SAMHSA-certified OTPs (Opioid Treatment Programs); most effective for severe OUD with daily supervised dosing; retention rates of 60-80% at 12 months
• Naltrexone (Vivitrol): Opioid antagonist that blocks euphoric effects for 28 days per injection; requires 7-14 days of opioid abstinence before initiation; reduces relapse risk by 36% versus placebo

Stage 3: Behavioral Therapies in Opioid Rehab

Evidence-based therapies used alongside MAT in opioid rehab treatment:

• Cognitive Behavioral Therapy (CBT): 12-16 session protocol that identifies and restructures triggers and drug-use thought patterns; reduces relapse rates by 30-50% when combined with MAT
• Contingency Management (CM): Provides tangible incentives for verified drug-free urine screens; shown in NIDA trials to improve treatment retention by 20-30%
• Trauma-Informed Care: Addresses PTSD and adverse childhood experiences (ACEs) — present in up to 60% of individuals with OUD — using EMDR or prolonged exposure therapy
• Motivational Interviewing (MI): Brief, patient-centered counseling that strengthens commitment to recovery and treatment adherence
• Family Therapy (CRAFT model): Trains family members in reinforcement strategies; increases treatment entry rates by 64% for resistant individuals

Opioid Rehab Treatment Program Lengths and Levels of Care

Typical program structures for opioid rehab treatment:

• Inpatient/Residential: 30, 60, or 90 days of 24/7 structured care; recommended for severe OUD, polysubstance use, or unstable living situations
• Partial Hospitalization (PHP): 5-7 days per week, 6+ hours daily; medical monitoring without overnight stay
• Intensive Outpatient (IOP): 3-5 days per week, 3-4 hours per session; allows continued work or school attendance
• Outpatient MAT: Weekly to monthly physician visits for medication management and counseling; suitable for stable patients in long-term recovery

Naloxone (Narcan): Overdose Prevention

Naloxone is an opioid antagonist that reverses overdose within 2-3 minutes when administered as a nasal spray (Narcan) or injection. Since the FDA approved over-the-counter naloxone in March 2023, it is available at pharmacies without a prescription. Quality opioid rehab treatment programs train patients, families, and staff in naloxone administration and provide take-home kits as part of discharge planning.

Long-Term Recovery and Relapse Prevention

Opioid use disorder requires ongoing management. Research published in the Journal of Substance Abuse Treatment shows that patients who remain in treatment for 12+ months have 2-3x higher long-term recovery rates. Long-term residential programs, sober living homes, peer recovery coaching, and mutual-aid groups (Narcotics Anonymous, SMART Recovery) provide sustained support. Browse verified opioid rehab treatment centers in our comprehensive directory.